Ketohexokinase Inhibition in Hereditary Fructose Intolerance
NCT06089265
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
8
Enrollment
OTHER
Sponsor class
Conditions
HFI
Interventions
DRUG:
PF-06801591
Sponsor
Maastricht University Medical Center
Collaborators
[object Object]